Med.rare--wish I could buy a lot more under $4 like you had, but unless Q4 earnings report is real bad, this stock may never again see a 3 in front of it...and depending on upcoming guidance, stock may never see a 4 in front if it. Go HEK!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.